<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04137770</url>
  </required_header>
  <id_info>
    <org_study_id>20-002</org_study_id>
    <nct_id>NCT04137770</nct_id>
  </id_info>
  <brief_title>Application of the ICE-T Postoperative Multimodal Pain Regimen to Laparoscopic Hysterectomy</brief_title>
  <official_title>Application of the ICE-T Postoperative Multimodal Pain Regimen to Laparoscopic Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mercy Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mercy Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial evaluating whether application of ice packs and&#xD;
      scheduled ketorolac to the surgical site after laparoscopic hysterectomy reduces need for&#xD;
      narcotic medications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who undergo laparoscopic hysterectomy and chose to participate in the study will be&#xD;
      randomized to either receive the standard post-surgical analgesic protocol (control group) or&#xD;
      the standard post-surgical analgesic protocol plus scheduled ketorolac and surgical site ice&#xD;
      packs. Usage of narcotic analgesics for breakthrough pain will be monitored and compared&#xD;
      between cohorts. All care received by test subjects will be standard of care, with the only&#xD;
      difference being the use of ice packs and scheduled ketorolac.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid analgesic usage in the 24 hours immediate post-operative period</measure>
    <time_frame>24 hours</time_frame>
    <description>Opioid analgesic usage in the 24 hours immediately post-operative as measured in Morphine Milligram Equivalents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid analgesic usage for 6 weeks post-operative</measure>
    <time_frame>6 weeks</time_frame>
    <description>Opioid analgesic usage for 6 weeks post-operative as measured in Morphine Milligram Equivalents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores in the 24 hours immediate post-operative period</measure>
    <time_frame>24 hours</time_frame>
    <description>Pain scores (on a scale of 1-10, 10 being worse pain) as documented by the floor nurse in the patient's chart in the 24 hours immediate post-operative period</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will receive routine post-operative analgesics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive routine post-operative analgesics plus scheduled ketorolac and surgical site ice packs</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ice pack and ketorolac</intervention_name>
    <description>Scheduled IV ketorolac will be administered and ice packs will be applied to the surgical site</description>
    <arm_group_label>intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Females, 18-65 years old at time of new patient evaluation, Planned laparoscopic&#xD;
        hysterectomy only or hysterectomy with or without unilateral or bilateral oophorectomy or&#xD;
        salpingo-oophorectomy by Dr. Corey Wagner, Uterus with expected size greater than 250 grams&#xD;
        as determined by bimanual exam or standard of care ultrasound obtained prior to or as part&#xD;
        of new patient evaluation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Diagnosed or suspected endometriosis, Diagnosis of malignant carcinoma of the uterus,&#xD;
        ovaries, or fallopian tubes, Diagnosis of severe renal disease (as determined by a GFR of&#xD;
        less than 45), Known nonsteroidal anti-inflammatory drug (NSAID) intolerance, History of&#xD;
        myocardial infarction, stroke or other cardiovascular disease, Known hypersensitivity or&#xD;
        allergic reactions to Acetaminophen, Toradol, Ibuprofen, other NSAIDs, Aspirin or&#xD;
        Roxicodone, Previous diagnosis of liver disease or hepatitis, Unable to take Tylenol&#xD;
        (acetaminophen), Pre-existing narcotic drug regimens or opioid use disorders, Known&#xD;
        diagnosis of or history of peptic ulcer disease, gastrointestinal bleeding or perforation,&#xD;
        Known or suspected gastrointestinal obstruction including paralytic ileus, Diagnosis of&#xD;
        severe bronchial asthma, Known diagnosis or history of cerebrovascular bleeding, Known&#xD;
        bleeding disorder or coagulopathy based on patient history unless excluded by appropriate&#xD;
        hematological examination, Daily prescription NSAID use, Adults unable to consent,&#xD;
        Pregnancy as determined by urine or serum pregnancy test obtained in women of child-bearing&#xD;
        age, Prisoners, Individuals who do not read and understand English&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corey A Wagner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mercy St. Louis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Derek Smith</last_name>
    <phone>314-251-5761</phone>
    <email>Derek.Smith2@Mercy.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Corey Wagner, MD</last_name>
    <phone>314-251-7650</phone>
    <email>corey.wagner@mercy.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mercy Hospital St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek Smith</last_name>
      <phone>314-251-5761</phone>
      <email>Derek.Smith2@Mercy.net</email>
    </contact>
    <investigator>
      <last_name>Corey A Wagner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kael A Murphy Pettis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacquelyn F Mirr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 18, 2019</study_first_submitted>
  <study_first_submitted_qc>October 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2019</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketorolac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

